| Title |
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
|
|---|---|
| Published in |
Trials, June 2020
|
| DOI | 10.1186/s13063-020-04422-y |
| Pubmed ID | |
| Authors |
Christina M. Eckhardt, Matthew J. Cummings, Kartik N. Rajagopalan, Sarah Borden, Zachary C. Bitan, Allison Wolf, Alex Kantor, Thomas Briese, Benjamin J. Meyer, Samuel D. Jacobson, Dawn Scotto, Nischay Mishra, Neena M. Philip, Brie A. Stotler, Joseph Schwartz, Beth Shaz, Steven L. Spitalnik, Andrew Eisenberger, Eldad A. Hod, Jessica Justman, Ken Cheung, W. Ian Lipkin, Max R. O’Donnell |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Switzerland | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 329 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 329 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 44 | 13% |
| Researcher | 41 | 12% |
| Student > Bachelor | 40 | 12% |
| Student > Ph. D. Student | 21 | 6% |
| Other | 20 | 6% |
| Other | 60 | 18% |
| Unknown | 103 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 111 | 34% |
| Nursing and Health Professions | 26 | 8% |
| Biochemistry, Genetics and Molecular Biology | 11 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 3% |
| Agricultural and Biological Sciences | 7 | 2% |
| Other | 44 | 13% |
| Unknown | 119 | 36% |